| |
| |
|
| Insider
Information: |
Thero John F |
| Relationship: |
Director |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
3,367,084 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,825,648 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,367,084 |
|
|
| Total
Value |
$2,825,648 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 7.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acusphere Inc |
ACUSD |
Former Senior VP/CFO |
2007-08-28 |
91,504 |
2004-07-06 |
0 |
Premium* |
|
|
Amarin Corp Plc |
AMRN |
|
2021-07-30 |
3,252,752 |
2012-07-26 |
0 |
Premium* |
|
|
Cyteir Therapeutics, Inc. |
CYT |
Director |
2024-02-08 |
22,828 |
2022-05-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
118 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-01-29 |
4 |
D |
$7.50 |
$620,715 |
D/D |
(82,762) |
2,881,749 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-02-25 |
4 |
D |
$7.30 |
$1,122,295 |
D/D |
(153,739) |
3,118,706 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
390,696 |
3,272,445 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
86,311 |
3,194,413 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-02-26 |
4 |
D |
$6.74 |
$228,924 |
D/D |
(33,965) |
3,171,052 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,944 |
3,197,996 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-03-31 |
4 |
D |
$6.37 |
$67,547 |
D/D |
(10,604) |
3,187,392 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-04-30 |
4 |
D |
$5.24 |
$55,565 |
D/D |
(10,604) |
3,203,732 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,944 |
3,214,336 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,944 |
3,230,676 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-05-28 |
4 |
D |
$4.54 |
$48,142 |
D/D |
(10,604) |
3,220,072 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,944 |
3,247,016 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-06-30 |
4 |
D |
$4.48 |
$47,506 |
D/D |
(10,604) |
3,236,412 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,944 |
3,263,356 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2021-07-30 |
4 |
D |
$4.14 |
$43,901 |
D/D |
(10,604) |
3,252,752 |
0 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
Director |
– • – |
2022-05-10 |
4 |
B |
$2.00 |
$20,000 |
D/D |
10,000 |
10,000 |
2.39 |
% |
|
| CYT |
Cyteir Therapeutics, Inc. |
Director |
– • – |
2024-02-08 |
4 |
OE |
$1.69 |
$21,679 |
D/D |
12,828 |
22,828 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President and CEO |
• • – |
2019-08-21 |
4/A |
OE |
$2.50 |
$62,498 |
D/D |
24,999 |
2,313,310 |
0 |
- |
|
118 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
